Would like to think that both products would be up and running in many medical facilities within 18 months.That’s unless we get taken over within that time.This technology is game changing, plus it has future abilities in diagnosis in fatty liver so there is huge upside. As always, they keep ticking boxes on time.
EMV Price at posting:
$2.04 Sentiment: Buy Disclosure: Held
